Pa Fan Fan Hsiao

Dr. Pa Fan Fan Hsiao

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Dermatologica Sinica
Verified
Journal Article
Open access
Tsen-Fang TsaiTsen-Fang Tsai
Tsen-Fang Tsai
JHJi-Chen Ho
Ji-Chen Ho
YCYi-Ju Chen
Yi-Ju Chen
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
WLWoan-Ruoh Lee
Woan-Ruoh Lee
YHYu-Huei Huang
Yu-Huei Huang

1 October 2006 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
CHCheng-Hsiang Hsiao
Cheng-Hsiang Hsiao
Tsen-Fang TsaiTsen-Fang Tsai
Tsen-Fang Tsai
SJShiou-Hwa Jee
Shiou-Hwa Jee

19 October 2016 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
SKSantosh U. Kafle
Santosh U. Kafle
SSSai Myint Swe
Sai Myint Swe
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
YTYi‐Chiun Tsai
Yi‐Chiun Tsai
YWYu-Hung Wu
Yu-Hung Wu

3 June 2024 in Cosmetics
Verified
Journal Article
Open access
PDF file
PLPo-Hsuan Lu
Po-Hsuan Lu
XYXiao-Feng Yao
Xiao-Feng Yao
YLYang-Chih Lin
Yang-Chih Lin
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
The use of low-fluence picosecond (LFPS) 1064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers, referred to as laser toning, is increasingly acknowledged as an effective treatment for pigmentation disorders in the Asian skin phenotype. This study aimed to conduct a comparative analysis on the effectiveness and safety of utilizing LFPS 1064 nm Nd:YAG lasers against picosecond 532 nm Nd:YAG lasers in treating pigmented lesions among Chinese patients. A retrospective photographic analysis and chart reviews were performed on 31 subjects exhibiting Fitzpatrick skin types III–VI who underwent LFPS 1064 nm Nd:YAG or picosecond 532 nm Nd:YAG treatments at a single tertiary center. Utilizing VISIA Complexion Analysis, comparative photographs were taken. Two independent physicians evaluated treatment efficacy using a visual analog scale (VAS) to assess the percentage of pigmentary clearance in standard photographs. Solar lentigines were the most prevalent pigmentary disorder, followed by post-inflammatory hyperpigmentation (PIH), nevus zygomaticus, melasma, freckles, and nevus of Ota. The clinical effectiveness of picosecond 532 nm and LFPS 1064 nm laser treatments proved comparable for lesions on the face, with mean VAS scores of 2.2 ± 1.1 and 1.8 ± 0.8, respectively. There were two cases of PIH in the picosecond 532 nm group, which resolved within one month. Overall, the LFPS 1064 nm laser demonstrates promise as a safe and efficient therapeutic modality for managing pigmented lesions in Chinese patients.

1 November 2022 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
WCWayne Chou
Wayne Chou
YWYu-Hung Wu
Yu-Hung Wu
Acquired dermal melanocytosis (ADM) is a pigmented lesion caused by melanocytes in the dermis, and it is most often observed on the face of young and middle-aged Asian women. ADM development may be associated with melanin synthesis alterations, but little evidence of its molecular and histological alteration has yet been reported. This study aimed to evaluate ADM in different body locations using different immunohistochemical and chemical staining techniques. This retrospective case series includes consecutive patients confirmed as ADM by biopsy between 2001 and 2018. Patient data and archival images were used to determine the pattern and duration of skin lesions, as confirmed by data analysis of immunohistopathological staining of skin biopsy specimens. A total of 22 ADM patients were included with mean age at diagnosis of 47 years, and 63.6% were female. The most common site was limbs (36.4%), followed by face (27.3%), trunk (22.7%), and scalp (13.6%). Melanin levels were highest in the face and upper extremities and lowest in the trunk. All participants had perivascular distribution of dermal melanocytes, particularly on the face and limbs. The perineural distribution of dermal melanocytes was observed in the lower limbs, with prominent inflammation and fibrosis on the scalp. Dermal melanocytes expressed most markers recognizing melanocytes except for CD117. Analysis of this ADM case series has confirmed that melanin is activated by dermal melanocytes that may aggregate along blood vessels. CD117 may be a useful biomarker by which to identify the migration of epidermal melanocytes.

13 December 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
CHChin-Ling Hsieh
Chin-Ling Hsieh
PHPa Fan Fan Hsiao
Pa Fan Fan Hsiao
Currently, over 200,000 new cases of leprosy are reported annually worldwide. Although leprosy was thought to have been eradicated in Taiwan, a few new cases still occur annually. Protean clinical manifestations of leprosy and immunological reactions result in delayed diagnoses. In addition, drug-resistant leprosy is emerging and poses treatment challenges. In this retrospective study, we collected and analyzed the clinicopathological features, leprosy type, treatment response, and relapse rate of patients with leprosy in our hospital between January 2009 and November 2022. We found that 54% of patients were Indonesian, and borderline lepromatous leprosy was predominant (39%); moreover, histoid leprosy and the Lucio phenomenon were also reported. Polymerase chain reaction analysis identified four positive cases, including a dapsone-resistant (4%) case. Our findings indicated good control of leprosy and a lower rate of dapsone resistance than that reported by the World Health Organization (4% vs. 13%) from 2009 to 2015. We found that the patient profile in terms of the treatment duration, recurrence rate, systemic symptoms, and neurological symptoms did not differ between before and during the pandemic. We report the recent advances in leprosy diagnosis, drug-resistant gene mutations, post-exposure prophylaxis, vaccination, and the effect of coronavirus disease 2019 on leprosy to facilitate updated leprosy diagnosis and management.